Cancer Research Cancer Research Funding Available  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 7860, October 1, 2009. Published Online First September 29, 2009;
doi: 10.1158/0008-5472.CAN-09-0801
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-09-0801v1
69/19/7860    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Helzer, K. T.
Right arrow Articles by Forsyth, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helzer, K. T.
Right arrow Articles by Forsyth, A.

Systems Biology and Emerging Technologies

Circulating Tumor Cells Are Transcriptionally Similar to the Primary Tumor in a Murine Prostate Model

Kimberly T. Helzer1, Helen E. Barnes1, Laura Day1, Jeanne Harvey2, Paul R. Billings2 and Allyn Forsyth1

1 ICx Biosystems, La Jolla, California and 2 CELLective Dx, Mountain View, California

Requests for reprints: Jeanne Harvey, On-Q-ity, 610 Lincoln St., Waltham, MA 02451. Phone: 781-895-8100; Fax: 781-890-4636; E-mail: jeanne.harvey{at}On-Q-ity.com.

Key Words: circulating tumor cells • metastases • xenograft • transcriptional profiling • laser capture microscopy

The abundance of circulating tumor cells (CTC) indicates patient prognosis. Molecular characterization of CTCs may add additional information about a patient's disease. However, currently available methods are limited by contamination with blood cells. We describe a study using a modified CTC-chip to capture CTCs from an orthotopic xenograft model. Using laser capture microscopy to collect CTCs from the chip, we compared transcripts from purified CTCs with those from primary and metastatic tissue. Transcriptional profiles showed strong concordance among primary, metastatic, and CTC sources. Moreover, cells captured on the chip were viable and could be expanded in culture. We conclude that the CTC-chip is a useful tool to further characterize animal models of cancer and that viable CTCs can be isolated and show transcriptional similarity to solid tumors. [Cancer Res 2009;69(19):7860–6]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.